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“Splicing speckles” are major nuclear domains rich in components of the splicing machinery and polyA RNA. Although
speckles contain little detectable transcriptional activity, they are found preferentially associated with specific mRNA-
coding genes and gene-rich R bands, and they accumulate some unspliced pre-mRNAs. RNA polymerase II transcribes
mRNAs and is required for splicing, with some reports suggesting that the inactive complexes are stored in splicing
speckles. Using ultrathin cryosections to improve optical resolution and preserve nuclear structure, we find that all forms
of polymerase II are present, but not enriched, within speckles. Inhibition of polymerase activity shows that speckles do
not act as major storage sites for inactive polymerase II complexes but that they contain a stable pool of polymerase II
phosphorylated on serine2 residues of the C-terminal domain, which is transcriptionally inactive and may have roles in
spliceosome assembly or posttranscriptional splicing of pre-mRNAs. Paraspeckle domains lie adjacent to speckles, but
little is known about their protein content or putative roles in the expression of the speckle-associated genes. We find that
paraspeckles are transcriptionally inactive but contain polymerase II, which remains stably associated upon transcrip-
tional inhibition, when paraspeckles reorganize around nucleoli in the form of caps.
INTRODUCTION
The cell nucleus is a complex organelle that harbors chro-
mosomes organized into territories as well as many subcom-
partments rich in protein complexes with roles in DNA and
RNA metabolism. “Splicing speckles,” or interchromatin gran-
ule clusters at the ultrastructural level, are major nuclear do-
mains that are rich in components of the splicing machinery
and polyA RNA (Lamond and Spector, 2003), but they also
contain other nuclear proteins with roles in RNA metabolism
and transcription, including RNA polymerase II (pol II) and
CDK9 (Mintz et al., 1999; Herrmann and Mancini, 2001). Speck-
les are often found spatially associated with “paraspeckle”
domains, which are marked by paraspeckle proteins (PSPs) 1
and 2 (Fox et al., 2002). The protein content of paraspeckles
suggests that they are involved in RNA synthesis or process-
ing; PSPs interact with the splicing and transcription fac-
tor-associated proteins p54nrb/NonO and PSF, respectively,
which in turn interact with pol II (Emili et al., 2002; Kameoka
et al., 2004; Myojin et al., 2004; Fox et al., 2005).
The discovery that the association of splicing factors and
polyA RNA with speckles is highly dynamic has suggested
that these domains are metastable compartments (Kruhlak et
al., 2000; Phair and Misteli, 2000; Molenaar et al., 2004).
However, speckles remain stable in unfixed permeabilized
cells for many hours and resist biochemical purification
(Mintz et al., 1999), such that some of their components are
likely to be structural. Although speckles are mostly devoid
of chromatin and are not major sites of transcription, as
measured after incorporation of labeled nucleotides into
nascent RNAs (Puvion and Puvion-Dutilleul, 1996; Iborra et
al., 1998; Cmarko et al., 1999), specific mRNA-coding genes
and gene-rich R bands have been found preferentially asso-
ciated with them (Clemson and Lawrence, 1996; Johnson et
al., 2000; Shopland et al., 2002, 2003; Moen et al., 2004). That
unspliced mRNAs are present and further accumulate upon
splicing inhibition (Johnson et al., 2000) suggests a role for
speckles in gene expression and possibly posttranscriptional
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splicing of pre-mRNAs for which splicing is not completed
cotranscriptionally.
Messenger RNAs and some small structural RNAs are tran-
scribed by pol II. Its largest subunit (RPB1) contains an unusual
C-terminal domain (CTD) with multiple tandem heptad re-
peats of consensus sequence Tyr1Ser2Pro3Thr4Ser5Pro6Ser7 (52
repeats in mammals), which is required for RNA processing
(Maniatis and Reed, 2002; Zorio and Bentley, 2004) and for
recruitment of splicing factors to sites of transcription (Misteli
and Spector, 1999). Phosphorylation of the CTD correlates with
steps of the transcription cycle; hypophosphorylated pol II is
thought to bind to promoters, becoming phosphorylated on
Ser5 residues during transcription initiation and on Ser2 once
elongation begins (Kobor and Greenblatt, 2002). Several studies
have reported enrichment of Ser2P pol II in splicing speckles
relative to the nucleoplasm (Bregman et al., 1994, 1995; Bisotto
et al., 1995; Mortillaro et al., 1996; Zeng et al., 1997; Patturajan et
al., 1998; Mintz and Spector, 2000), proposing a model in which
speckles serve as reservoirs of polymerase complexes that are
mobilized to supply sites of active transcription. In contrast,
other reports indicate a homogeneous distribution of Ser2P
pol II throughout the nucleoplasm (Grande et al., 1997; Zeng et
al., 1997). These different results may depend on experimental
differences such as the antibodies used and cell preparation
conditions (Guillot et al., 2004). Although, live cell experiments
using enhanced green fluorescent protein (EGFP)-tagged RPB1
reveal a homogeneous distribution of pol II throughout the
nucleoplasm (Sugaya et al., 2000; Kimura et al., 2002), these
experiments do not exclude the possibility that some forms
of the enzyme might be enriched, or cycle through splicing
speckles.
Here, we have examined the role of splicing speckles as
reservoirs of pol II by systematic localization of the differ-
ently phosphorylated forms of pol II in the nucleus of con-
trol and transcriptionally inhibited HeLa cells. We show that
splicing speckles are not major sites of pol II storage, al-
though they contain a small population of Ser2P pol II com-
plexes that are stably bound but transcriptionally inactive.
We also characterize the pol II content and transcriptional
activity of the speckle-associated paraspeckle domains.
MATERIALS AND METHODS
Cell Culture, Bromo-UTP–labeled RNA (Br-RNA) Labeling,
Fixation and Ultrathin (Tokuyasu) Cryosectioning
HeLa cells were grown in 5% CO2 at 37°C in DMEM, supplemented with 10%
heat-inactivated fetal calf serum, 2 mM l-glutamine, 100 IU/ml penicillin, 100
g/ml streptomycin, and 20 mM HEPES (all from Invitrogen, Paisley, United
Kingdom). -Amanitin (-am) (50 g/ml; Sigma Chemical, Poole, Dorset,
United Kingdom) was added to cultures for 5 h before fixation or whole cell
extract preparation.
To label sites of transcription, cells were permeabilized with saponin in a
“physiological buffer” containing bovine serum albumin (BSA), and incu-
bated (15 min) in 0.1 M Br-UTP and the other NTPs before fixation (Pombo et
al., 1999b). Cells were fixed in 4% freshly depolymerized paraformaldehyde in
250 mM HEPES (pH 7.6; 10 min; 4°C), refixed in 8% paraformaldehyde in 250
mM HEPES (pH 7.6; 2 h; 4°C), scrapped, and pelleted during the latter
fixation (Pombo et al., 1999a). Pellets were embedded (2 h) in 2.1 M sucrose in
phosphate-buffered saline (PBS), transferred onto a copper block, frozen, and
stored in liquid nitrogen. Cryosections (100–150 nm in thickness) were cut
with a glass knife using an ultracryomicrotome (UltraCut UCT52; Leica,
Milton Keynes, United Kingdom), captured on drops of 2.1 M sucrose in PBS,
transferred to 0.17-mm-thick coverslips for immunofluorescence, and used
immediately or stored at 20°C.
Antibodies
Primary antibodies to the largest subunit of pol II were as follows. H224 was
raised against recombinant protein corresponding to amino acids 1-224 at the
amino terminus (rabbit IgG; 1:100 [Western blot; WB] and 1:10 [immunoflu-
orescence, IF]; Santa Cruz Biotechnology, Santa Cruz, CA). ARNA-3 recog-
nizes an epitope delineated by amino acids 794-822 outside the CTD (mouse
IgG; 1:500 [WB] and 1:50 [IF]; Research Diagnostics, Flanders, NJ]. 8WG16
preferentially recognizes nonphosphorylated heptads of the CTD (mouse IgG;
1:100 [WB and IF]; BioDesign International, Saco, ME; Patturajan et al., 1998;
Cho et al., 2001). Although some 8WG16 batches have been reported to
contain significant cross-reactivity to faster migrating bands (Bregman et al.,
1995), the one used here shows only a relatively minor reaction with an
additional band (Figure 1B, arrow). Rabbit anti-Ser5P recognizes phosphory-
lated Ser5 peptides (rabbit IgG; 1:3000 [WB] and 1:1000 [IF]; Schroeder et al.,
2000]. 4H8 was raised against phosphorylated Ser5 (mouse IgG; 1:2  105
[WB] and 1:500 [IF]; Upstate Biotechnology, Lake Placid, NY]. H5 recognizes
phosphorylated Ser2 (mouse IgM; 1:500 [WB] and 1:2000 [IF]; Covance,
Princeton, NJ; Patturajan et al., 1998; Komarnitsky et al., 2000). H5 cross-
reactivities with Ser5P peptides and phosphorylated SR proteins have been
described in highly purified systems (Cho et al., 2001; Doyle et al., 2002;
Licatalosi et al., 2002; Jones et al., 2004) but do not seem to contribute to the
staining observed in whole cells or extracts (see Discussion). Other available
Ser2P antibodies available so far are not specific for pol II (CC-3; Lavoie et al.,
1999) or also recognize Ser5P epitopes (mara-3 and B3; Patturajan et al., 1998;
Cho et al., 2001).
Primary antibodies to splicing factors were as follows: SC35 recognizes a
phosphorylated epitope within the serine/arginine (SR) domain of the spli-
ceosome assembly factor, a member of the SR family of non-small nuclear
ribonucleoprotein-splicing proteins (mouse IgG1; 1:1500; Sigma Chemical; Fu
and Maniatis, 1990); Sm recognizes Sm protein, a spliceosomal factor (human
autoimmune antibodies; 1:2000; ANA-CDC).
Other primary antibodies were mouse anti-BrdU (1:1000; Caltag Laborato-
ries, Burlingame, CA) and sheep anti-bromodeoxyuridine (BrdU) (1:200;
BioDesign International); and rabbit anti-PSP1 (1:150; Fox et al., 2002). Sec-
ondary antibodies conjugated with fluorescein isothiocyanate (FITC) or Cy3
were obtained from Jackson ImmunoResearch Laboratories (West Grove, PA)
(multiple labeling grade), with AlexaFluor488 or AlexaFluor555 from Molecular
Probes (Eugene, OR), and with horseradish peroxidase (HRP) from Promega. For
double-labeling using an IgM (H5) and an IgG (SC35; Figure 3, J and K),
secondary antibodies raised in donkey against - or -immunoglobulin chains
(Jackson ImmunoResearch Laboratories) were used, respectively. Control exper-
iments in the absence of each primary antibody showed no detectable cross-
reaction (our unpublished data).
Western Blotting
Total HeLa cell protein extract was prepared by harvesting HeLa cells in SDS
sample buffer (10% Ficoll, 2.5 mM EDTA, 25 mM Na3PO4, 0.5% SDS, 0.1%
bromphenol blue, 10% -mercaptoethanol, 1 mM NaF, and 1 mM phenyl-
methylsulfonyl fluoride) and by passing three times through a 21-gauge
needle. Denatured total protein extracts (2  105–3  105 cells/well) were
separated by SDS-PAGE on 4–15% Tris-HCl gradient gels (Criterion precast
gel system; Bio-Rad, Hertsfordshire, United Kingdom) and transferred to
nitrocellulose membranes (Bio-Rad). Membranes were blocked (1 h) in 5%
milk in Tris-buffered saline/Tween 20 (TBS-T) buffer (10 mM Tris-HCl, pH
8.0, 150 mM NaCl, and 0.05% Tween 20), incubated (2 h) in primary antibod-
ies, washed (30 min), incubated (1 h) in HRP-conjugated secondary antibod-
ies, and washed (30 min) all in 5% milk in TBS-T. Blots were washed in TBS-T,
before detection of the HRP signal with ECL detection reagent (GE Health-
care, Little Chalfont, Buckinghamshire, United Kingdom), and exposed to
Hyperfilm ECL (GE Healthcare). Scanned images were contrast stretched in
Adobe Photoshop (Adobe Systems, Edinburgh, United Kingdom).
Immunofluorescence Labeling
Cryosections were rinsed (3 times) in PBS, incubated (30 min) in 20 mM
glycine in PBS, rinsed (3 times) in PBS, treated (10 min) with 0.1% Triton X-100
in PBS, blocked (1 h) with PBS (PBS supplemented with 1% BSA, 0.2% fish
skin gelatin, and 0.1% casein; pH 7.6), incubated (2 h) with primary antibodies
(in PBS), washed (3 times; 1 h) in PBS, incubated (1 h) with secondary
antibodies against mouse, rabbit, or human IgGs in PBS, rinsed (3 times; 30
min) in PBS, rinsed (3 times) in PBS, counterstained (45 min) with TOTO-3
(2 M; Molecular Probes) in 0.05% Tween 20 in PBS, and rinsed successively
in 0.05% Tween 20 in PBS and then PBS, before coverslips were mounted in
VectaShield (Vector Laboratories, Peterborough, United Kingdom). The long
incubation times used allow for antibody accessibility throughout the thick-
ness of cryosections, providing the highest sensitivity (Branco et al., 2005).
Negative controls included omission of primary antibodies and treatment of
cryosections with alkaline phosphatase (AP) (2 h; 37°C) (0.5 U/l, calf intes-
tinal; New England Biolabs, Hitchin, Hertsfordshire, United Kingdom) before
immunolabeling, to test the specificity of anti-pol II antibodies to phosphor-
ylated epitopes.
Double labeling experiments were generally carried out simultaneously by
combining both primary antibodies and both secondary antibodies, except
when testing for the presence of pol II or Br-RNA within paraspeckles. In this
case, to prevent false negative results because of antibody blocking, sections
were first incubated with primary antibody against pol II or Br-RNA, washed,
incubated with secondary antibody, washed (30 min) and incubated with
primary antibodies anti-PSP1, and corresponding secondary antibodies.
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Fluorescence In Situ Hybridization to PolyA RNA
PolyA RNA was detected with an FITC-labeled poly(dT) probe (Sigma
Chemical) in hybridization mixture (Sigma Chemical) to give 1 M final
concentration. RNA-fluorescence in situ hybridization was performed with
molecular biology grade reagents (RNAse- and DNAse-free). After immuno-
labeling, sections were refixed (2 h) with 4% paraformaldehyde in PBS and
washed (16 h) in PBS. Sections were incubated (15 min) with 2 mM vanadyl
ribonucleoside complex (Sigma Chemical) in PBS (15 min), in 20 mM glycine
in DEPC-treated PBS (10 min) with 0.1% Triton X-100, in DEPC-phosphate-
buffered saline, and then washed (4 times) in 2 SSC. Hybridization mixture
(5 l) containing FITC-poly(dT) was denatured (10 min; 70°C), applied on
Hybrislips (Molecular Probes) before covering with coverslips (10 mm in
diameter) containing sections, sealed with rubber cement (Marabuwerke,
Tamm, Germany), and hybridized for 60 h at 42°C. Coverslips were then
washed in 2 SSC (2 times; 1 h; 20°C), in 1 SSC (2 times; 15 min), and in
0.5 SSC (15 min), and incubated (30 min) with casein blocking solution
(containing 2.6% NaCl, 0.5% BSA, and 0.1% fish skin gelatin, pH 7.5–8.0;
Vector Laboratories). The FITC-poly(dT) signal was amplified (2 h) with
AlexaFluor488 rabbit anti-FITC (1:500; Molecular Probes), washed (3 times;
1 h), incubated (1 h) with rabbit anti-AlexaFluor488 (1:1000; Molecular
Probes), washed (3 times; 1 h), and incubated (1 h) with AlexaFluor488 goat
anti-rabbit (Molecular Probes), all in casein-blocking solution. Cryosections were
counterstained with TOTO-3 as described above. Control experiments in the
absence of poly(dT) probe in the hybridization mixture or pretreatment (1 h;
37°C) with 250 g/ml RNAse A in 2 SSC showed no detectable signal (our
unpublished data).
Microscopy
Images were acquired on a confocal laser scanning microscope (Leica TCS
SP2, 100 objective, numerical aperture 1.4; Leica Camera, Milton Keynes,
United Kingdom), equipped with argon (488-nm) and HeNe (543-, 633-nm)
lasers, and pinhole equivalent to 1 Airy disk. Images from the different
channels were collected sequentially to prevent bleedthrough. For compari-
son of different treatments, images were collected on the same day using
the same settings, and without saturation of the intensity signal. For an unbiased
representation of the whole nuclear volume, nuclear profiles were selected
randomly on the TOTO-3 channel, regardless of whether sections contained
splicing speckles (Supplemental Figure S2, A and C). Raw TIFF images were
merged and analyzed in Adobe Photoshop (Adobe Systems) without further
thresholding or filtering (e.g., no background subtraction).
Quantitative and Statistical Analyses
The quantification procedure used for splicing speckles is summarized in
Supplemental Figure S2, D. Masks were drawn in the merged images, around
the nucleoplasm (excluding nucleoli) in the TOTO-3 channel, around speckles
in the “splicing speckle” channel, and in areas of the image outside cells
(background). The areas of nucleoplasm and speckles were recorded (in
pixels) for each nuclear profile in the image, and the average intensities per
pixel measured within the “speckle,” “nucleoplasm,” and “background”
masks using the Histogram function for the speckle marker (Figure 2) or pol
II (Figure 3) channels.
Speckle volume was calculated as a percentage of the nucleoplasm after
calculation of the percentage of nucleoplasmic area occupied by speckles (i.e.,
Figure 1. Characterization of antibodies against different forms of RNA polymerase II. (A) Schematic diagram for the binding sites of
different antibodies against total and phosphorylated forms of the largest subunit of pol II (RPB1; n, number of CTD repeats). (B) Western
blot analyses of HeLa whole cell extracts with antibodies against different forms of the largest subunit of pol II. Arrows indicate minor
cross-reactivities. (C–L) The different forms of RPB1 are found in discrete sites throughout the nucleoplasm (dotted line), mostly outside
nucleoli (arrows), with a minor fraction of unphosphorylated pol II found in the cytoplasm (arrowheads). Insets represent nucleic acid
staining with TOTO-3. Total pol II was detected with antibodies H224 (C) and ARNA3 (D) against non-CTD epitopes of RPB1 in cryosections
from HeLa cells. Pol IIA was detected with 8WG16 (E and F); pretreatment of sections with AP increases 8WG16 immunolabeling intensity
by 1.5 times (F). Phosphorylated Ser5 pol II was detected with rabbit anti-Ser5P (G) and 4H8 (I) antibodies; absence of signal after pretreatment
of sections with AP (H and J) shows that both antibodies bind specifically to phosphorylated epitopes. Phosphorylated Ser2 pol II was
detected with H5 (K); H5 immunolabeling signal is also sensitive to AP (L). Bar, 2 m.
RNA Polymerase II and Splicing Speckles
Vol. 17, April 2006 1725
the ratio between area speckles and area of nucleoplasm), because the thick-
ness of sections is significantly thinner than the size of the speckles and is
equal throughout the nuclear section. Volume data were compiled from
single- and double-labeling experiments, because data comparisons showed
that the presence of antibodies to pol II during immunolabeling of speckles
has no statistically significant effect on measurements of volume (ANOVA
with blocking for different experiments; our unpublished data). The effect of
-amanitin on speckle volume was analyzed by ANOVA test with blocking
(independent labeling experiments were considered as different blocks).
Average “background” intensity (per pixel) was subtracted from the inten-
sities in the nucleoplasm and in speckles for each image. The total nucleo-
plasmic (np) levels of speckle markers or polymerase II was normalized
relative to untreated controls (Supplemental Figure S2, D.3). For SC35, Sm,
and polyA RNA, nucleoplasmic intensities were measured in images from
single-labeling experiments (Figure 2C), to avoid bias because of antibody
steric hindrance detected in double-labeling experiments (our unpublished
data). Results for total pol II levels represented in Figure 3 (red bars) come
from double-labeling experiments but were confirmed in singly labeled cryo-
sections (our unpublished data), with no significant differences.
The content of speckle markers or pol II in speckles was represented as a
proportion of total nucleoplasmic content. For each nuclear profile, average
intensities (per pixel) in the nucleoplasm and in speckles were subtracted
from the image background and multiplied by the number of pixels in
nucleoplasmic and speckle areas, respectively. The relative intensity present
in speckles was calculated as a percentage of total intensity in the nucleo-
plasm and averaged for all sections analyzed (Supplemental Figure S2, D).
This value represents an average for the cell population and corrects for the
contribution of sections representing different regions of the nucleus. To
normalize the marker content in speckles in -amanitin–treated samples
relative to untreated controls, the average content was calculated as for
untreated samples, and this value was corrected with the normalized average
intensity (Supplemental Figure S2, D.4).
The effects of -amantin on total nucleoplasmic levels and on speckle
content were determined using a t test (assumptions 2-tailed distribution and
2-sample unequal variance).
For paraspeckles, masks were drawn around the domains, before scoring for
the presence of pol II or Br-RNA inside, over or outside the edge of masks. The
numbers of paraspeckles analyzed ranged from 12 to 29 and originated from
eight to 14 different nuclear profiles. The differences in pol II or Br-RNA local-
ization in paraspeckles were analyzed using the chi-square statistical test after
merging the values on the “edge” and “outside” speckles into one category.
RESULTS
Specificity of Pol II Antibodies and Distribution of
Different Forms of Pol II in the Nucleus of HeLa Cells
The eukaryotic nucleus contains inactive and active pol II
complexes that become phosphorylated on Ser2 and Ser5
residues at specific steps of the transcription cycle (Kobor
and Greenblatt, 2002). Active complexes account for only
approximately one-quarter of nuclear pol II (Jackson et al.,
1998; Kimura et al., 2002), most of which is thought to be
hyperphosphorylated. The presence of hyperphosphorylated
forms of pol II in a nuclear compartment can be an indicator of
transcriptional activity but requires confirmation by direct la-
beling of nascent transcripts, because not all hyperphospho-
rylated complexes in the cell are associated with DNA (War-
ren et al., 1992; Jackson et al., 1998; Kimura et al., 2002).
Conversely, the presence of hypophosphorylated pol II in a
compartment may suggest a role in storage of inactive pol II
complexes or could simply reflect some level of permeabil-
ity. A role in storage can be put in evidence by changing the
equilibrium between active and inactive complexes, for ex-
ample, after transcription inhibition with the drug -aman-
itin (Carmo-Fonseca et al., 1992; Spector et al., 1993).
We first tested the specificity of antibodies that recognize
different forms of the largest subunit of pol II, RPB1, in
Western blots and their labeling properties in fixed HeLa
cells (Figure 1; see Materials and Methods and supplemental
material for a detailed description of the properties of each
antibody). Six antibodies were highly specific for RPB1 in
Western blots, three antibodies with specificity for phos-
phorylated epitopes showed full sensitivity to AP, and all
gave consistent results by in situ immunofluorescence.
SDS-PAGE separates RPB1 molecules into two main bands,
IIA and IIO, which correspond to hypo- and hyperphosphory-
lated forms of the subunit, respectively, and an intermediate
smear with increasing levels of phosphorylation (Figure 1B).
Total pol II can be recognized by antibodies H224 and ARNA3,
which bind to non-CTD domains of RPB1 and therefore label
Figure 2. Effects of transcriptional inhibition on the volume of
speckles and content in SC35, Sm antigen, and polyA RNA relative
to the nucleoplasm. Cryosections of HeLa cells grown in the absence
(A, C, and D) or presence (B–D) of -am were indirectly immuno-
labeled with antibodies against SC35 or Sm antigen, or polyA RNA
detected after in situ hybridization with a poly(dT) probe. Nuclear
perimeters identified in TOTO-3 images (insets) were drawn as
white dotted lines. (A) SC35 is concentrated in euchromatic do-
mains and throughout the nucleoplasm. (B) Transcriptional inhibi-
tion by -am causes speckles to round up and increase accumula-
tion of SC35. Bar, 2 m. (C and D) The np fraction of Sm antigen,
SC35, or polyA RNA present in speckles was determined after
measuring the fluorescence intensity (C) and volume (D) in speckles
relative to nucleoplasm in control and -amanitin–treated cells.
Total average intensity levels of SC35, Sm, and polyA throughout
the nucleoplasm did not change with -amanitin relative to un-
treated samples (p  0.7). -Amanitin treatment causes statistically
significant enrichment of speckle markers in speckles (except for Sm
antigen; t test *p  0.05 or **p  0.01) and increase in speckle
volumes (ANOVA with blocking; ***p  0.003). Numbers of nuclear
profiles measured are shown in parentheses. Error bars represent
standard deviations.
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both pol IIA and IIO bands in Western blots of whole HeLa cell
extracts (Figure 1, A and B). The IIA form can be detected with
antibody 8WG16 raised against unphosphorylated CTD (Fig-
ure 1B), which also detects a minor fraction of slower migrating
molecules, but little of the IIO band (Figure 1B). For simplicity,
hereafter, we refer to the pol II molecules detected by 8WG16
as pol IIA. Pol II forms phosphorylated on Ser5 can be detected
with rabbit anti-Ser5P and 4H8 antibodies; both antibodies
Figure 3. RNA polymerase II is not recruited to splicing speckles upon transcriptional inhibition. Cryosections of HeLa cells grown in the
absence (A, D, G, and J) or presence (B, E, H, and K) of -am were indirectly immunolabeled with antibodies against different forms of pol
II and splicing speckle markers (SC35 or polyA RNA). Nuclear perimeters were identified in the TOTO-3 images and drawn as white dotted
lines or shown as an inset. Higher magnification images of speckles are shown on the right-hand side of lower magnification images. Bar,
2 m. The np fraction of pol II present in speckles is a ratio of total fluorescence intensity in speckles relative to total intensity throughout
the nucleoplasm (C, F, I, and L). The effects -amanitin on the total amounts of pol II in the nucleoplasm or in speckles are statistically
significant except for the amount of Ser2P pol II (L) in speckles, which remains constant (t test; **p  0.01 or ***p  0.001); numbers of nuclear
profiles measured are shown in parentheses). Error bars represent standard deviations. (A–C) Total pol II (H224; red) and SC35 (green) in
control (A) and -amanitin–treated (B) cells. A small fraction of total pol II is found in speckles; upon transcriptional inhibition, total pol II
levels decrease proportionally in both np and speckles (C). (D–F) Pol IIA (8WG16; red) and polyA RNA (green). A small fraction of pol IIA
is found within speckles; upon transcriptional inhibition, levels decrease in nucleoplasm and speckles (F), and a small number of brighter IIA
sites are seen around nucleoli (E; solid line). (G–I) Phosphorylated Ser5 pol II (rabbit anti-Ser5P; red) and SC35 (green). A small fraction of
phospho-Ser5 pol II is found in speckles, mostly at their periphery; upon transcriptional inhibition, levels decrease in both nucleoplasm and
speckles (I). (J–L) Phosphorylated Ser2 pol II (H5; red) and SC35 (green). A small fraction of phospho-Ser2 pol II is found in speckles; upon
transcriptional inhibition, levels decrease throughout the nucleoplasm, whereas levels within speckles remain constant (L).
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label the IIO form and a smear of faster migrating forms, but
not the IIA band (Figure 1B). Pol II complexes phosphorylated
on Ser2 can be detected with antibody H5 (Patturajan et al.,
1998), which exclusively detects the IIO band in whole cell
extracts, but not the IIA form or the intermediate smear, which
is detected by antibodies to Ser5P (Figure 1B; see Discussion for
comments on previously described cross-reactions of H5).
These results suggest that most “hypophosphorylated” IIA
molecules have little phosphorylation on Ser2 or Ser5 residues.
To characterize the in situ labeling patterns of each anti-
body in HeLa cells, we used ultrathin cryosections (100–150
nm in thickness) of sucrose-embedded cells because they
maximize antibody accessibility to nuclei fixed under con-
ditions that preserve ultrastructure (Figure S2, B; Guillot et
al., 2004; Branco et al., 2005), and they also improve the axial
resolution of confocal microscopes (Pombo et al., 1999a). All
pol II forms studied here are found in discrete sites outside
nucleoli, with a small number of brighter sites observed in
some nuclear sections (Figure 1, C–G, I, and K; note that
150-nm-thick cryosections correspond to 1/50 of a nu-
cleus with 5- to 10-m diameter). EGFP-RPB1 and other
subunits of pol II show similar distributions (Jones et al.,
2000; Sugaya et al., 2000). Antibodies against the N terminus
or nonphosphorylated CTD also detect pol II in the cyto-
plasm, where RPB1 is likely to be translated (Figure 1, C–F,
arrowheads). All detectable immunoreactivity of antibodies
to Ser5P or Ser2P pol II is sensitive to AP (Figure 1, H, J, and
L). Although all pol II forms have a homogeneous distribu-
tion in the nucleus of HeLa cells, without obvious concen-
tration in speckles, it remained possible that some forms of
pol II are specifically stored in these compartments.
Inhibition of Transcriptional Activity Induces Minor
Changes in the Volume and Splicing Factor
Enrichment of “Splicing Speckles”
To ask whether splicing speckles act as storage sites of pol II,
we first characterized speckles in our imaging conditions in
control and -amanitin–treated cells to reveal the extent of
recruitment because of transcriptional inhibition (Figure 2).
Comparisons of three markers of speckles, Sm antigen,
SC35, and polyA RNA, show they colocalize in large in-
terchromatin domains, as expected (Supplemental Figure
S1). As shown previously, splicing speckles become more
prominent after -amanitin treatment (Figure 2, A and B;
Carmo-Fonseca et al., 1992; Spector et al., 1993). To compare
the amount of splicing factors and polyA RNA concen-
trated in speckles relative to the nucleoplasm in control and
-amanitin–treated cells, we developed a simple stereologi-
cal procedure that involves computing the proportion of
intensity signal contained in speckles relative to the total
signal present throughout the nucleoplasm (see Materials and
Methods and Supplemental Figure S2). Speckles contain ap-
proximately one-fifth of the nucleoplasm content in SC35,
Sm antigen, and polyA RNA (25, 18, and 17%, respectively;
Figure 2C; see also Fay et al., 1997; Wei et al., 1999). The total
volume occupied by speckles is relatively small (5, 8, and 4%
of the nucleoplasm for speckles marked by SC35, Sm anti-
gen, and polyA RNA, respectively; Figure 2D), showing
that the splicing factor and polyA enrichment in speckles is
only two- to fourfold relative to the whole nucleoplasm. The
small differences between speckle markers are likely to re-
flect difficulties with identifying smaller speckles with SC35
and polyA RNA, which give more discrete patterns.
After -amanitin treatment in vivo, speckles round up
and seem more enriched in SC35 (Figure 2, A and B; Spector
et al., 1993). Unlike what might be predicted from visual
inspection of images, intensity measurements show that the
recruitment of SC35 into splicing speckles after transcrip-
tional inhibition is relatively small (increasing from 25 to
39% of total nucleoplasmic intensity after treatment with
-amanitin), but statistically highly significant (t test; p 
0.01). Only a marginal, but statistically significant increase,
is observed for polyA RNA, with no significant effect de-
tected in the case of Sm antigen (Figure 2C). The volume of
speckles increases slightly to 6, 10, and 6% of the nucleo-
plasm volume for SC35, Sm antigen, and polyA, respec-
tively (Figure 2D); the increase in volume relative to un-
treated cells for the three speckle markers is statistically
highly significant (ANOVA test; p  0.003).
Splicing Speckles Contain but Are Not Enriched in Any of
the Different Phosphorylated Forms of Pol II
We next tested whether any of the different pol II forms are
present in splicing speckles, using SC35 or polyA RNA as
markers, depending on the origin of the pol II antibodies
available (Figure 3; analyses using Sm antigen gave similar
results; our unpublished data). All forms of pol II are found
within speckles (Figure 3, A, D, G, and J) but in relative
amounts that are proportional to speckle volume (7, 7, 6, and
4% for total pol II, IIA, Ser5P, and Ser2P, respectively; Figure
3, C, F, I, and L), indicating that pol II is neither enriched nor
depleted in speckles relative to the whole nucleoplasm. Bio-
chemical purification of speckles is consistent with this re-
sult, because pol II copurifies with splicing speckles, but no
enrichment is detected relative to whole nuclear extracts
(Mintz et al., 1999).
Splicing Speckles Do Not Act as Nuclear Reservoirs of Pol
II but Contain a Small Pool of Stably Bound Ser2P Pol II
To reveal whether splicing speckles act as nuclear reservoirs of
inactive pol II complexes, we inhibited pol II activity with
-amanitin and measured whether the speckle content in pol II
increased. Cryosections from cells grown in the absence or
presence of -amanitin were immunolabeled in parallel and
imaged under the same, nonsaturating conditions. After -
amanitin treatment, the total nucleoplasmic levels of total pol
II, pol IIA, and Ser5P pol II decrease to 33, 34, and 26%, respec-
tively, relative to untreated cells (Figure 3, A–I). The levels
within speckles also decrease to approximately one-third (from
6 to 7 to1 to 2%), implying that pol II complexes in speckles
are not stably bound but in transit through these domains. The
reduction in total pol II levels was confirmed by Western blot
analyses for total pol II (Figure 4). Previous analyses of pol II
levels by Western blotting also show a decrease in pol II levels
induced by -amanitin (Bregman et al., 1995; Nguyen et al.,
Figure 4. Western blot analyses confirm reduction pol II levels
after treatment with -amanitin. HeLa cells were grown50 g/ml
-amanitin for 5 h, before whole cell extracts were prepared and
analyzed by Western blot with antibodies against total pol II (H224)
and Ser2P pol II (H5). Western with H224 reveals a decrease in the
levels of hyperphosphorylated (IIO band) and hypophosphorylated
(IIA band) forms of pol II. Western blots with H5 confirm a marked
reduction in the levels of Ser2P pol II.
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1996). Although Nguyen et al. (1996) reported complete degra-
dation of pol II after 4 h in 100 g/ml -amanitin (or 24 h in 20
g/ml), our results are consistent with those of Bregman et al.
(1995) in which some Ser5P pol II is detected after 8 h in 10
g/ml -amanitin (and after 3 h in 100 M 5,6-dichloro-1--
d-ribofuranosylbenzimidazole [DRB]). Such discrepancies are
likely to result from differences in sensitivity of Western blot-
ting protocols used in the different laboratories. We also con-
firmed the presence of pol II and reduction in levels after
-amanitin treatment on equatorial optical sections from whole
cells after immunolabeling with the same panel of antibodies
(Guillot, Martin, Antunes, Bentley, and Pombo, unpublished
data; also see Bregman et al., 1995). Alternative inhibitors of pol
II activity, such as DRB, also cause a reduction, albeit less
pronounced, of pol II levels in the nucleoplasm, and do not
cause detectable accumulation of pol II forms detected with
antibodies against total pol II in speckles (Guillot and Pombo,
unpublished data; also see Bregman et al., 1995). However, one
study claims that DRB has no effect on pol II levels (Nguyen et
al., 1996).
Careful analysis of pol IIA distribution in -amanitin–
treated cells also revealed the presence of a small number of
intensely labeled sites containing this form of pol II around
nucleoli (Figure 3E, solid line; also see Figure 6D), reminis-
cent of perinucleolar caps such as those seen with coilin,
fibrillarin, or paraspeckle protein (Fox et al., 2002; Ospina
and Matera, 2002). The perinucleolar pol IIA sites detected
by 8WG16 do not colocalize with polyA RNA (Figure 3E),
coilin, or fibrillarin (our unpublished data), but they do
colocalize with paraspeckle protein (see below).
In contrast to the other forms of pol II, the amount of Ser2P
pol II in speckles remained constant (5% of nucleoplasmic
intensity) after -amanitin treatment, whereas the reduction
detected in the nucleoplasm was more prominent (to 18%
relative to untreated cells; Figure 3, J–L; also confirmed by
Western blot, Figure 4, and by immunofluorescence analysis
of whole cells; Guillot and Pombo, unpublished data). Al-
though visual inspection of images has previously sug-
gested that Ser2P pol II is recruited from the nucleoplasm to
speckles upon transcriptional inhibition (Bregman et al.,
1995; Mintz and Spector, 2000), the intensity measurements
presented here dismiss this conclusion. The general decrease
in Ser2 phosphorylation in euchromatic areas is expected as
phosphorylation on Ser2 correlates with transcription elon-
gation, which is inhibited within 1 h of the -amanitin
treatment used here (measured after Br-UTP incorporation;
our unpublished data). The lack of sensitivity to -amanitin
and the absence of little detectable chromatin in splicing
speckles suggest that the pol II molecules present in speckles
are not engaged in transcription. The use of other inhibitors
of pol II activity, such as DRB, also revealed a stable pool of
Ser2P pol II in speckles (Guillot and Pombo, unpublished;
also see Bregman et al., 1995).
To confirm that Ser2P pol II complexes present in speckles
are transcriptionally inactive, we localized sites of transcrip-
tion relative to speckles after incorporation of Br-UTP into
newly made RNA. We labeled nascent RNAs in cells per-
meabilized with a mild detergent in conditions that preserve
cellular ultrastructure and the activity of all three nuclear
polymerases (I, II, and III), while preventing any detectable
movement of completed RNAs down the transport pathway
(Iborra et al., 1996; Pombo et al., 1999b). Br-RNA was de-
tected at the edges of speckles (Figure 5; Puvion and Puvion-
Dutilleul, 1996; Iborra et al., 1998; Cmarko et al., 1999), unlike
what is observed for Ser2P pol II (Figure 3K).
The presence of Br-RNA at the periphery of speckles is
consistent with identification of active genes in this region.
Although previous analyses of whole cells reported 15–45%
of Br-RNA signal in the nucleoplasm is present within nu-
clear speckles (Fay et al., 1997; Wei et al., 1999), our higher
resolution approach finds only 5% of Br-RNA at the edge
of speckles (marked by SC35 or polyA RNA).
Paraspeckles Contain Pol IIA but Little Ser2P Form or
Newly Made Br-RNA
We next investigated whether the splicing-associated, paraspeckle
domains contained pol II or could be involved in the transcrip-
tional events that take place at the speckle periphery. Because
paraspeckles are too small to act as main reservoirs of pol II, we
scored the number of parapeckles that contained pol II (Figure 6),
instead of measuring the relative content of pol II. Total pol II
marked by non-CTD antibodies is found within most paraspeck-
les (77%) or at their periphery (23%; Figure 6, A and G). The
presence of pol II within these domains was confirmed with
antibody 8WG16 to hypophosphorylated forms (with or without
pretreatment with AP to remove phospho groups; Figure 6, B and
G); 8WG16 labels 95% of paraspeckles, probably because of the
increased sensitivity afforded by the detection of multiple heptad
repeats in the CTD.
Because paraspeckles relocate to the periphery of the nucle-
olus after transcriptional inhibition with actinomycin D and
DRB (Fox et al., 2002, 2005), in the form of cap structures such
as those observed here for pol IIA after -amanitin treatment
(Figure 2E), we investigated whether pol II remained stably
associated with paraspeckles in these conditions. We found pol
IIA colocalized in the same nucleolar caps as PSP1 (Figure 6D),
but not coilin (our unpublished data), indicating that the asso-
ciation between nonphosphorylated pol II and PSP1 in
paraspeckles is likely to be stable (Figure 6D).
Ser5P and Ser2P pol II were both found within paraspeckles
but only in 31 and 11% of the domains, respectively (Figure 6,
C, E, and G); most of the remaining paraspeckles were sur-
rounded by these forms of pol II. To test whether the pol II
complexes present within paraspeckles are transcriptionally
active, we labeled nascent transcripts after incorporation of
Br-UTP. Most paraspeckles do not contain but are surrounded
by Br-RNA (Figure 5, F and G; Fox et al., 2002). These results
indicate that although paraspeckles may be involved in pol II
metabolism, they are unlikely to be sites of transcription. Chi-
square statistical test showed that differences in the frequency
of colocalization of pol II forms or Br-RNA within paraspeckles
Figure 5. Splicing speckles are not transcriptionally active. Newly
labeled Br-RNA (red) was found over the edges of, but not within
splicing speckles marked by SC35 (green). Higher magnification
view of speckle inside white box is shown on the right hand side.
Bar, 2 m.
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are highly significant (p  0.0001). The differences in localiza-
tion between Ser5P and Ser2P forms and Br-RNA also indicate
that the presence of phosphorylated forms of pol II within a
nuclear domain does not necessarily imply that the domain is
transcriptionally active, as seen previously for Cajal bodies
(Schul et al., 1998; Xie and Pombo, 2005).
DISCUSSION
RNA Polymerase II Is Present but Not Enriched within
Splicing Speckles
Splicing speckles are major nuclear domains that occupy
5–10% of the nucleoplasmic volume and are enriched in
splicing factors and polyA RNA by a factor of 2 to 4
relative to the nucleoplasm (Figure 2; Fay et al., 1997; Wei et
al., 1999). We find that all forms of pol II studied here are
present in splicing speckles (Figure 3), but in contrast with
previous reports, we do not detect an enrichment of Ser2P
pol II, nor of any other pol II form, in these ultrastructurally
preserved samples (Bregman et al., 1995; Mintz and Spector,
2000; Guillot et al., 2004). A small pool of hyperphosphory-
lated pol II is also detected in speckles after biochemical
purification of these compartments (Mintz et al., 1999).
Transcription Occurs at the Edge of but Not within
Splicing Speckles
Here, we confirm that the interior of speckles is transcrip-
tionally inactive, because little nucleotide incorporation into
RNA is detected (also see Puvion and Puvion-Dutilleul,
1996; Iborra et al., 1998; Cmarko et al., 1999). However, a
growing number of genes have been found associated with
speckles (Shopland et al., 2003; Moen et al., 2004). The reso-
lution of confocal microscopes is limited by the diffraction of
light; on the z-axis, it is at best 500 nm and in the size range
of most speckles. As suggested from the three- to ninefold
overestimation of transcriptional activity in speckles after
whole cell measurements of Br-RNA (Fay et al., 1997; Wei et
al., 1999) relative to higher resolution achieved after the use
of ultrathin sections (Figure 5; Puvion and Puvion-Dutilleul,
1996; Iborra et al., 1998; Cmarko et al., 1999), some of the
associations detected between specific genes and speckles in
confocal micrographs of whole cells are likely to be too
distant to be biologically meaningful. Nevertheless, the ac-
cumulation of transcripts in speckles and their enrichment
after splice-site mutation provides compelling evidence that
some pre-mRNAs cycle through speckles to complete splic-
ing or as a quality control mechanism for unprocessable
transcripts (Johnson et al., 2000). Transient association of
polyA RNAs with speckles has also been recently observed
in vivo using fluorescent 2	-O-methyl oligoribonucleotide
probes (Molenaar et al., 2004).
Figure 6. Paraspeckles are not transcriptionally active but contain
pol II. Paraspeckles contain total pol II (A; detected with ARNA-3),
pol IIA (B; detected with 8WG16), and Ser5P pol II (C; detected with
4H8). Higher magnification views of paraspeckles inside white box
are shown below each low-power image. Pol IIA colocalizes in PSP1
nucleolar caps formed after -am treatment (arrow in D). Little
detectable Ser2P pol II or Br-RNA is found within paraspeckles (E
and F). The magnified views in the last row show two additional
examples of paraspeckle domains in which Ser2P or Br-RNA were
found inside or at the edge of paraspeckles, respectively. Bar, 2 m.
(G) Quantitative analysis of the number of paraspeckles containing
pol II or Br-RNA outside (red), at the edge of (orange), or inside
(green) the domains. Numbers of paraspeckles analyzed are shown
in parentheses. The chi-square statistical test was performed after
merging the values on the ”edge“ and ”outside“ speckles into one
category; differences were found to be highly significant (p 
0.0001).
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Inhibition of Transcription Does Not Result in Pol II
Recruitment to Speckles but Reveals a Stably Bound Pool
of Ser2P Pol II Complexes
Because the nuclear dynamics of phosphorylated forms can-
not so far be assessed by live cell imaging, we set out to
analyze the stability of pol II association with speckles after
inhibition of pol II transcription. If speckles were storage
sites for RNA pol II, transcriptional inhibition should result
in an enrichment of pol II in these domains. We find the
opposite is true (Figure 3); total pol II levels throughout the
nucleoplasm and within speckles decrease proportionally,
arguing against a function of splicing speckles as a pool of
inactive pol II complexes. These results are consistent with
the “sponge-like” properties of splicing speckles recently
characterized in the Xenopus oocyte nucleus (Handwerger et
al., 2005), and with the idea that pol II complexes cruise
through these permeable nuclear compartments.
The hyperphosphorylated Ser2P pol II showed a different
behavior. Although no enrichment was detected, the levels
of Ser2P pol II complexes in speckles remained constant after
transcriptional inhibition, whereas levels in the nucleoplasm
were greatly diminished. This suggests that Ser2P complexes
in speckles represent a stable component of these domains
that do not freely exchange with the nucleoplasm.
Cross-reactivity of H5 with Ser5P CTD peptides and phos-
phorylated SR proteins has been identified in highly purified
systems (Cho et al., 2001; Doyle et al., 2002; Licatalosi et al.,
2002; Jones et al., 2004). However, a number of arguments
indicate that these cross-reactivities have little contribution
to the staining detected in situ after immunofluorescence.
First, Ser5P pol II is significantly reduced in speckles after
-amanitin, unlike the epitope detected by H5, which re-
mains constant (Figure 3). Second, H5 does not bind to Cajal
bodies, although these domains are rich in the Ser5P form
(Schul et al., 1998; Doyle et al., 2002; Xie and Pombo, 2005). It
is more difficult to rule out that some of the H5 staining in
speckles is because of cross-reactivity to hyperphosphory-
lated SR proteins. However, it is generally thought that
hyperphosphorylated SR proteins reside outside speckles
(Gui et al., 1994; Colwill et al., 1996; Neugebauer and Roth,
1997). Finally, the presence of hyperphosphorylated RPB1
and other pol II subunits in speckles is also detected by mass
spectrometry after biochemical purification of these com-
partments (Mintz et al., 1999).
Because phosphorylated pol II is required for splicing
(Hirose et al., 1999) and promotes assembly of spliceosomes
(Zeng and Berget, 2000), an intriguing possibility for the role
of Ser2P pol II in speckles is that the CTD may serve as a
platform for posttranscriptional splicing of long transcripts
known to traffic through speckles and accumulate in these
domains when they contain a splice-site mutation (Johnson
et al., 2000). Although CTD truncation has no effect on splic-
ing of injected -globin pre-mRNA in Xenopus oocytes (Bird
et al., 2004), it remains possible that the specific pre-mRNAs
found to accumulate in speckles in mammalian cells require
a phosphorylated CTD for posttranscriptional splicing. Be-
cause splicing speckles are present in cells that contain a
CTD-truncated RPB1, the CTD itself is unlikely to be a
structural component of these domains (Misteli and Spector,
1999). Three other arguments show that Ser2P modification
is not exclusively associated with transcriptionally active
complexes and may have roles other than in transcription.
First, Ser2P complexes are present in mitotic cells when pol
II is inactive (Bregman et al., 1994), with potential roles in
inactivation of transcription initiation and splicing factor
recruiting to the nucleus upon nuclear envelope formation.
Second, 10% of Ser2P pol II in the cell is not resistant to
treatment with the detergent sarkosyl and therefore is prob-
ably transcriptionally inactive (Jackson et al., 1998). Third,
Ser2P complexes within speckles are insensitive to -aman-
itin (Figure 3K) and DRB (Bregman et al., 1995).
Paraspeckles Are Not Sites of Transcription but Are
Stably Associated with Pol IIA
Paraspeckles are marked by PSP1 and PSP2 proteins, which
interact with CTD-binding proteins, such as p54nrb and PSF,
and are found at the periphery of splicing speckles (Emili et
al., 2002; Fox et al., 2002, 2005; Kameoka et al., 2004; Myojin
et al., 2004), where active genes are also associated. We tested
whether paraspeckles contain pol II or are sites of transcrip-
tion and found that they contain the Ser5P form of pol II but
little of the Ser2P form or newly made Br-RNA (Figure 6).
Furthermore, upon transcriptional inhibition, pol II and
p54nrb remain stably bound to paraspeckles when they
relocate to the periphery of nucleoli (Figure 6D; Fox et al.,
2005). The presence of pol II in paraspeckles and the cycling
of these compartments between splicing speckles and nucle-
oli suggests a role in pol II recycling, but it remains unclear
why some pol II complexes would be transported to and
from the periphery of nucleoli.
In summary, our results show that splicing speckles and
paraspeckles are likely to be involved in pol II metabolism
but are not major sites of gene transcription or polymerase II
storage. It remains to be determined whether the Ser2P pol II
complexes present in speckles are required for posttran-
scriptional splicing that may occur in these domains.
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Supplemental Materials 
“Splicing speckles are not reservoirs of RNA polymerase II, but contain an      
inactive form, phosphorylated on Serine2 residues of the CTD.” 
 
Sheila Q. Xie, Sonya Martin, Pascale V. Guillot, David L. Bentley and Ana Pombo 
 
 
Labeling properties of antibodies to different forms of pol II. 
 
Antibodies that detect total pol II outside the CTD (H224 and ARNA-3) 
Antibodies H224 and ARNA3 bind to non-CTD domains of RPB1 (Figure 1A) and 
detect total pol II. As expected H224 and ARNA3 label both pol IIA and IIO bands 
in western blots of whole HeLa cell extracts with little other activities (Figure 1B).  
Total pol II is found in discrete sites outside nucleoli, with a small number of 
brighter sites observed in some nuclear sections (Figure 1C,D). EGFP-pol II 
shows similar distribution (Sugaya et al., 2000). H224 and ARNA3 also label the 
cytoplasm, where RPB1 is likely to be translated (Figure 1C,D; arrowheads). H224 
also labels a small number of sites within nucleoli (Figure 1C, arrow); these may 
correspond to a minor cross-reactivity or non-specific background staining, as 
they are not detected with the CTD-specific antibodies (Figure 1F). 
 
Antibodies that detect hypophosphorylated pol II (8WG16) 
Antibody 8WG16 binds to unphosphorylated heptad repeats, and more weakly to 
Ser5-phosphorylated repeats (Figure 1A; Patturajan et al., 1998; Cho et al., 2001; 
Doyle et al., 2002). Phosphorylation on Ser2 residues prevents binding of 8WG16 
to CTD heptad repeats, whereas Ser5 phosphorylation only partially reduces 
binding. 8WG16 has previously been used as a marker of total pol II (Bregman et 
al., 1995), under the assumption that some unphosphorylated heptad repeats are 
present in most IIO molecules. However, in total protein extracts prepared in the 
presence of phosphatase inhibitors, 8WG16 detects little of the IIO band (Figure 
1B; see also Doyle et al., 2002). This indicates that the vast majority of pol IIO 
molecules in HeLa cells have most of its heptad repeats phosphorylated on Ser2 
and/or Ser5. Pre-treatment of blots with AP confirms that phosphorylation, and not 
conformational changes on the CTD, prevent 8WG16 binding (not shown; see 
also Doyle et al., 2002). As most pol II molecules detected by 8WG16 correspond 
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to the IIA form, 8WG16 is not a good marker of total pol II unless samples are 
pretreated with alkaline phosphatase. 
Pol IIA is found in discrete sites throughout the nucleoplasm, with 1-3 
brighter sites (see also Bregman et al., 1995), and also a minor fraction in the 
cytoplasm (Figure 1E) as observed with antibodies H224 and ARNA3. As 
expected, pre-treatment of cryosections with alkaline phosphatase, in conditions 
that remove all detectable Ser2P and Ser5P epitopes (Figure 1H,J,L), increases 
the intensity of the nucleoplasmic signal detected by 8WG16 (by 1.5 fold; Figure 
1F). The use of 8WG16 after alkaline phosphatase treatment is likely to 
significantly enhance the sensitivity of the immunofluorescence assay, as the 
epitope detected is present 42 times in the canonical CTD repeats. This 
experiment confirms that total pol II is found concentrated in discrete sites 
throughout the nucleoplasm. 
 
Antibodies that detect pol II phosphorylated on Ser5 residues of the CTD 
(rabbit anti-Ser5P and 4H8) 
Pol II phosphorylated on Ser5 has previously been detected with antibody H14 
(Patturajan et al., 1998) and was found in discrete sites throughout the nucleoplasm 
(Bregman et al., 1995; A.P., not shown). However, recent batches of this antibody 
give variable results (see also Komarnitsky et al., 2000; Ahn et al., 2004)); we found 
that the commercial form of this antibody does not give specific or sensitive staining 
of Ser5P pol II in cryosections unlike the original formulation (not shown; Warren et 
al., 1992). Different commercial batches were tested.  
Alternative antibodies, rabbit anti-Ser5P and 4H8, have recently become 
available. Rabbit anti-Ser5P binds to CTD heptad-repeat tetramers containing 
Ser5P, but not Ser2P (Schroeder et al., 2000). 4H8 is a commercial antibody raised 
against Ser5P peptides, but is not fully characterized. 4H8 immunoprecipitates pol II 
at promoter sequences (Metivier et al., 2004) and it detects pol II in discrete sites in 
mammalian cells (Osborne et al., 2004). Although it has been reported that 4H8 
detects both hypo- and hyperphosphorylated forms of pol II in yeast extracts 
(Kristjuhan et al., 2002), our western analyses of human cell extracts prepared in 
the presence of phosphatase inhibitors show otherwise. In western blots, rabbit 
anti-Ser5P and 4H8 detect the IIO band and a smear of faster migrating forms, but 
not the IIA band (Figure 1B; for equivalent results with antibody H14, see Zeng and 
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Berget, 2000). This suggests that most IIA molecules in HeLa cells are not 
phosphorylated on Ser5 residues. Ser5P pol II detected with either antibody is 
distributed in discrete nucleoplasmic sites and a few brighter sites (Figure 1G,I). 
Alkaline phosphatase treatment (Figure 1H,J) demonstrates the specificity of these 
two antibodies to phosphorylated epitopes. 
 
Antibodies that detect pol II phosphorylated on Ser2 residues of the CTD 
(H5) 
Phosphorylation on Ser2 correlates with transcription elongation and therefore is 
likely to be the best marker for active polymerase. Pol II phosphorylated on Ser2 
can be detected with antibody H5, with increased affinity when Ser5 is also 
phosphorylated (Patturajan et al., 1998; Cho et al., 2001; Licatalosi et al., 2002; 
Jones et al., 2004). H5 exclusively detects the IIO band in whole cell extracts, but 
not the IIA form, or the intermediate smear that is detected by antibodies to Ser5P 
(Figure 1B; see also Zeng and Berget, 2000).  
Immunofluorescence analysis using H5 shows Ser2P pol IIO in discrete 
sites throughout the nucleoplasm, with occasional brighter sites in some sections 
(Figure 1K; see also Warren et al., 1992; Grande et al., 1996; Pombo et al., 1998; 
Guillot et al., 2004); as expected, cytoplasmic (inactive) pol II is not 
phosphorylated on this epitope. Ser2P pol II marked by H5 has previously been 
observed predominantly in splicing speckles (Bregman et al., 1994; Bregman et 
al., 1995; Zeng et al., 1997; Mintz and Spector, 2000), but this distribution results 
from low-stringency fixation procedures or harsher permeabilization treatments 
that disrupt nuclear ultrastructure and induce loss of nuclear proteins (Guillot et 
al., 2004). Alkaline phosphatase pre-treatment reveals the high specificity of H5 to 
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Supplemental Figure S1. Colocalization of Sm antigen, SC35 and polyA+ RNA in 
the nucleus of HeLa cells. Cryosections were indirectly immunolabeled with 
antibodies against Sm antigen and/or SC35, prior to fluorescence in situ 
hybridization to polyA+ RNA using a poly-dT probe. Higher magnification images of 
regions inside white boxes are shown on the right hand side of each lower 
magnification image. Bar, 2 µm.  
(A) Sm antigen (red) and SC35 (green), (B) Sm antigen (red) and polyA+ RNA 
(green), (C) SC35 (red) and polyA+ RNA (green). As expected, the largest and 
brightest speckles labeled by the different markers coincide, although the labeling 
pattern is not strictly colocalized. Sm antigen (A,B) marks speckles and an 
interconnected meshwork, whilst SC35 (A,C) labels discrete domains with little 
interconnection. PolyA+ RNA is found in discrete foci that are scattered throughout 
the nucleoplasm and cytoplasm, as expected for the distribution of polyadenylated 
mRNAs, and are enriched in “splicing speckles” (B,C). 
 
Supplemental Figure S2. Using cryosections for quantitative immunofluorescence.  
(A) Procedure. Tissues are fixed, embedded in a sucrose solution that acts as a 
cryoprotectant, and quickly frozen in liquid nitrogen. Ultrathin cryosections (100-150 
nm thick) are cut on an ultracryomicrotome at –100ºC, thawed on a drop of sucrose 
and transferred to coverslips (for fluorescence microscopy). The sucrose that 
embeds the section is washed away before immunolabelling, and images are 
collected on a confocal microscope. The different cellular profiles present in a 
cryosection (along red lines; S1-4) originate from different cells in the tissue and 
represent the different parts of the nucleus. Pale yellow, cytoplasm; blue, nucleus; 
aqua, nucleoli; green, splicing speckles.  
(B) Ultrastructure. The stringent fixation used to prepare cryosections (4 and 8% 
freshly-depolymerized paraformaldehyde in HEPES buffer; Guillot et al., 2004) 
preserves the organization of cellular organelles at the ultrastructural level. Bar 500 
nm. 
(C) Immunofluorescence. Cryosections from cells grown in the absence (-) or 
presence (+) of α-amantin (α-am) were indirectly immunolabelled with antibodies 
against SC35 and Ser2P pol II, and counterstained with TOTO-3 (pseudocoloured 
green, red and blue, respectively). Bar 5 µm. 
(D) Quantification. The stereological quantification procedure summarized here 
provides information on the speckle content relative to the whole nucleoplasm (for 
pol II, splicing factors or polyA+), and on the effects of the drug α-amanitin on 
nucleoplasm levels, partition in speckles and speckle volume. Note that this 
quantification is independent of the absolute thickness value, as section thickness 
(~100-150 nm) is much smaller than the size of speckles (~1 µm) and is equal 
throughout the nucleus. px, pixel; au, arbitrary units. 
 
S.Q.Xie, Figure S1, Supplemental Data
A Sm / SC35
B Sm / polyA+
C SC35 / polyA+
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